Fellowship · La Jolla, CA
Sponsored by University of California (San Diego) Medical Center · Director Irine Vodkin
A multisociety Delphi consensus statement on new fatty liver disease nomenclature.
Journal of hepatology · 2023 · 2,696 citations · Rohit Loomba
A multisociety Delphi consensus statement on new fatty liver disease nomenclature.
Hepatology (Baltimore, Md.) · 2023 · 2,397 citations · Rohit Loomba
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis.
The New England journal of medicine · 2024 · 1,637 citations · Rohit Loomba
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease.
Hepatology (Baltimore, Md.) · 2023 · 2,087 citations · Rohit Loomba
Tirzepatide for Metabolic Dysfunction-Associated Steatohepatitis with Liver Fibrosis.
The New England journal of medicine · 2024 · 761 citations · Rohit Loomba
Mechanisms and disease consequences of nonalcoholic fatty liver disease.
Cell · 2021 · 1,660 citations · Rohit Loomba
Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention.
Nature reviews. Gastroenterology & hepatology · 2021 · 1,542 citations · Rohit Loomba
A multisociety Delphi consensus statement on new fatty liver disease nomenclature.
Annals of hepatology · 2024 · 542 citations · Rohit Loomba